课题基金 / 基金详情

Identification of brain-permeant small molecule modulators of GAL1R receptor

Identification of brain-permeant small molecule modulators of GAL1R receptor
GAL1R 受体脑渗透性小分子调节剂的鉴定
批准号:
10005003
负责人:
Matthew Hall
金额:
$4.76万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:

项目摘要

项目成果

Matthew Hall的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The mu opioid receptor is the major target of most potent analgesics (e.g. morphine). However, severe side effects such as dependence and respiratory depression have been associated with this receptor. Members of this project team have reported that a significant population of mu-opioid receptors (MOR) localized in the ventral tegmental area (VTA) form heteromers with galanin Gal1 receptors (GAL1R) which modulate dopamine cell function. As such, these MOR-GAL1R heteromers may represent a potential target for the treatment of opioid use disorder. The project team intends to screen in-house libraries to identify small molecules modulating GAL1R receptor. The hits will be profiled for selectivity, and medicinal chemistry will be undertaken for select molecules to further improve their efficacy and potency.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
qHTS to Identify Inhibitors of Mutant and Wildtype NSD2
qHTS to Identify Activators and Inhibitors of Wip1
qHTS to Identify Compounds against Merkel Cell Carcinoma (MCC)
qHTS to Identify Activators of hTERT
海外基金